DiaMedica Therapeutics
In Leon Cooperman's portfolio · Omega Advisors
Ticker DMAC
Still in the portfolio as of Q3 2026. Every quarter it shows up in a Omega Advisors 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | No change | 3,450,000 | 0.9% |
| Q2 2026 | Add 71% | 3,450,000 | 0.7% |
| Q1 2026 | No change | 2,020,000 | 0.4% |
| Q4 2025 | Reduce 38% | 2,020,000 | 0.5% |
| Q3 2025 | Add 98% | 3,269,761 | 0.6% |
| Q2 2025 | Add 2% | 1,650,000 | 0.2% |
| Q1 2025 | No change | 1,625,000 | 0.2% |
| Q4 2024 | Add 7% | 1,625,000 | 0.3% |
| Q3 2024 | Add 8% | 1,511,739 | 0.3% |
| Q2 2024 | Add 58% | 1,400,000 | 0.2% |
| Q1 2024 | No change | 883,623 | 0.1% |
| Q4 2023 | Add 1% | 883,623 | 0.1% |
| Q3 2023 | No change | 875,993 | 0.1% |
| Q2 2023 | Add 1% | 875,993 | 0.2% |
| Q1 2023 | Add 7% | 868,413 | 0.1% |
| Q4 2022 | No change | 812,508 | 0.1% |
| Q3 2022 | No change | 812,508 | 0.1% |
| Q2 2022 | No change | 812,508 | 0.1% |
| Q1 2022 | Add 171% | 812,508 | 0.1% |
| Q4 2021 | Add 50% | 300,000 | 0.1% |
| Q3 2021 | Add 300% | 200,000 | 0.0% |
| Q1 2021 | Add 67% | 50,000 | 0.0% |
| Q4 2020 | Buy | 30,000 | 0.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.